Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (21-30 of 252) with videos related to

Pageof 26
Sort By:
Inflammatory Bowel Diseases|January 15, 2013
Tacrolimus in the management of hospitalized patients with steroid-refractory ulcerative colitis: don't forget cytomegalovirus!Xavier Roblin, Emilie Del Tedesco
European Journal of Clinical Investigation|July 16, 2010
Thiopurine metabolism monitoring: implications in inflammatory bowel diseasesOlivier Dewit, Peter Starkel, Xavier Roblin
Alimentary Pharmacology & Therapeutics|May 24, 2021
Editorial: total anti-drug antibodies detected using drug-tolerant assays during induction with anti-TNF therapy are associated with treatment failure-out of sight but not out of mind. Authors' replyXavier Roblin, Stephane Nancey, Stéphane Paul
Archives of Internal Medicine|November 24, 2004
Celiac disease must be evaluated in patients with Sjögren syndromeXavier Roblin, Frederic Helluwaert, Bruno Bonaz
World Journal of Gastroenterology|February 16, 2016
Cytomegalovirus and ulcerative colitis: Place of antiviral therapySylvie Pillet, Bruno Pozzetto, Xavier Roblin
Annals of Internal Medicine|March 7, 2018
Prolonged Persistence of Adalimumab Transferred From Mother to Infant During PregnancyRemi Labetoulle, Xavier Roblin, Stéphane Paul
Alimentary Pharmacology & Therapeutics|July 31, 2021
Letter: predicting treatment discontinuation in inflammatory bowel disease-anti-TNF trough levels and anti-drug antibodies. Authors' replyXavier Roblin, Stephane Nancey, Stéphane Paul
Expert Opinion on Biological Therapy|May 5, 2017
Golimumab for the treatment of ulcerative colitisMathurin Flamant, Stephane Paul, Xavier Roblin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 16, 2020
Preanalytical Heterogeneity in Fecal Calprotectin Measurement Needs To Be Considered for Tight ControlCeline Pansart, Xavier Roblin, Stephane Paul
Journal of Crohn'S & Colitis|January 24, 2018
Low Doses of Azathioprine are Effective in Combination With Infliximab in Inflammatory Bowel Disease but May not be During Induction TherapyXavier Roblin, B Flourié, Stephane Paul
Pageof 26

Showing results (21-30 of 252) with videos related to

Sort By:
Pageof 26
Inflammatory Bowel Diseases|January 15, 2013
Tacrolimus in the management of hospitalized patients with steroid-refractory ulcerative colitis: don't forget cytomegalovirus!Xavier Roblin, Emilie Del Tedesco
European Journal of Clinical Investigation|July 16, 2010
Thiopurine metabolism monitoring: implications in inflammatory bowel diseasesOlivier Dewit, Peter Starkel, Xavier Roblin
Alimentary Pharmacology & Therapeutics|May 24, 2021
Editorial: total anti-drug antibodies detected using drug-tolerant assays during induction with anti-TNF therapy are associated with treatment failure-out of sight but not out of mind. Authors' replyXavier Roblin, Stephane Nancey, Stéphane Paul
Archives of Internal Medicine|November 24, 2004
Celiac disease must be evaluated in patients with Sjögren syndromeXavier Roblin, Frederic Helluwaert, Bruno Bonaz
World Journal of Gastroenterology|February 16, 2016
Cytomegalovirus and ulcerative colitis: Place of antiviral therapySylvie Pillet, Bruno Pozzetto, Xavier Roblin
Annals of Internal Medicine|March 7, 2018
Prolonged Persistence of Adalimumab Transferred From Mother to Infant During PregnancyRemi Labetoulle, Xavier Roblin, Stéphane Paul
Alimentary Pharmacology & Therapeutics|July 31, 2021
Letter: predicting treatment discontinuation in inflammatory bowel disease-anti-TNF trough levels and anti-drug antibodies. Authors' replyXavier Roblin, Stephane Nancey, Stéphane Paul
Expert Opinion on Biological Therapy|May 5, 2017
Golimumab for the treatment of ulcerative colitisMathurin Flamant, Stephane Paul, Xavier Roblin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 16, 2020
Preanalytical Heterogeneity in Fecal Calprotectin Measurement Needs To Be Considered for Tight ControlCeline Pansart, Xavier Roblin, Stephane Paul
Journal of Crohn'S & Colitis|January 24, 2018
Low Doses of Azathioprine are Effective in Combination With Infliximab in Inflammatory Bowel Disease but May not be During Induction TherapyXavier Roblin, B Flourié, Stephane Paul
Pageof 26